» Articles » PMID: 24706839

Extended Lifespan and Reduced Adiposity in Mice Lacking the FAT10 Gene

Overview
Specialty Science
Date 2014 Apr 8
PMID 24706839
Citations 27
Authors
Affiliations
Soon will be listed here.
Abstract

The HLA-F adjacent transcript 10 (FAT10) is a member of the ubiquitin-like gene family that alters protein function/stability through covalent ligation. Although FAT10 is induced by inflammatory mediators and implicated in immunity, the physiological functions of FAT10 are poorly defined. We report the discovery that FAT10 regulates lifespan through pleiotropic actions on metabolism and inflammation. Median and overall lifespan are increased 20% in FAT10ko mice, coincident with elevated metabolic rate, preferential use of fat as fuel, and dramatically reduced adiposity. This phenotype is associated with metabolic reprogramming of skeletal muscle (i.e., increased AMP kinase activity, β-oxidation and -uncoupling, and decreased triglyceride content). Moreover, knockout mice have reduced circulating glucose and insulin levels and enhanced insulin sensitivity in metabolic tissues, consistent with elevated IL-10 in skeletal muscle and serum. These observations suggest novel roles of FAT10 in immune metabolic regulation that impact aging and chronic disease.

Citing Articles

Metabolomics biomarkers of frailty: a longitudinal study of aging female and male mice.

Zhu D, Wu J, Griffin P, Samuelson B, Sinclair D, Kane A bioRxiv. 2025; .

PMID: 39896479 PMC: 11785134. DOI: 10.1101/2025.01.22.634160.


The dichotomic role of cytokines in aging.

Silva R Biogerontology. 2024; 26(1):17.

PMID: 39621124 DOI: 10.1007/s10522-024-10152-4.


FAT10 inhibits TRIM21 to down-regulate antiviral type-I interferon secretion.

Saxena K, Inholz K, Basler M, Aichem A Life Sci Alliance. 2024; 7(9).

PMID: 38977311 PMC: 11231494. DOI: 10.26508/lsa.202402786.


The identification of a novel shared therapeutic target and drug across all insulin-sensitive tissues under insulin resistance.

Xu J, Zhu L, Xu J, Lin K, Wang J, Bi Y Front Nutr. 2024; 11:1381779.

PMID: 38595789 PMC: 11002099. DOI: 10.3389/fnut.2024.1381779.


The case for FAT10 as a novel target in fatty liver diseases.

Wimalarathne M, Wilkerson-Vidal Q, Hunt E, Love-Rutledge S Front Pharmacol. 2022; 13:972320.

PMID: 36386217 PMC: 9665838. DOI: 10.3389/fphar.2022.972320.


References
1.
Fontana L, Klein S . Aging, adiposity, and calorie restriction. JAMA. 2007; 297(9):986-94. DOI: 10.1001/jama.297.9.986. View

2.
Danilova O, Tai A, Mele D, Beinborn M, Leiter A, Greenberg A . Neurogenin 3-specific dipeptidyl peptidase-2 deficiency causes impaired glucose tolerance, insulin resistance, and visceral obesity. Endocrinology. 2009; 150(12):5240-8. PMC: 2795711. DOI: 10.1210/en.2009-0386. View

3.
Brasaemle D . Thematic review series: adipocyte biology. The perilipin family of structural lipid droplet proteins: stabilization of lipid droplets and control of lipolysis. J Lipid Res. 2007; 48(12):2547-59. DOI: 10.1194/jlr.R700014-JLR200. View

4.
Gong P, Canaan A, Wang B, Leventhal J, Snyder A, Nair V . The ubiquitin-like protein FAT10 mediates NF-kappaB activation. J Am Soc Nephrol. 2009; 21(2):316-26. PMC: 2834541. DOI: 10.1681/ASN.2009050479. View

5.
Pedersen B, Fischer C . Physiological roles of muscle-derived interleukin-6 in response to exercise. Curr Opin Clin Nutr Metab Care. 2007; 10(3):265-71. DOI: 10.1097/MCO.0b013e3280ebb5b3. View